Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) Stock Reacts Positively After Research Agreement
If you are currently looking into the possibility of investing in biopharmaceutical stocks, then it could be the right time to look into the Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) stock. It had emerged as one of the major gainers yesterday and ended up with gains of as much as 24% amidst heavy interest. Trading Data On Monday, NAVB stock soared 23.20% to $0.8870 with more than 1.78 million shares, compared to…